Table 1.

Factor VIII levels in plasma and characterization of anti–factor VIII autoantibodies in 3 patients with acquired hemophilia A

PatientPlasma levelInhibitor neutralization by FVIII domain, %Inhibition of IgG binding to FVIII, %
FVII:C (U/dL)FVII:Ag (U/dL)Anti-FVII:C (BU/mL)80-kd LCh72-kd LChHChC2A280-kd LCh72-kd LChHChC2A2
4.1 101 4.9 > 95 > 95 < 5 < 5 < 5 > 95 > 95 < 5 < 5 < 5 
4.3 98 3.5 > 95 > 95 < 5 < 5 < 5 > 95 > 95 < 5 < 5 < 5 
3.6 87 5.3 > 95 > 95 < 5 < 5 < 5 > 95 > 95 < 5 < 5 < 5 
PatientPlasma levelInhibitor neutralization by FVIII domain, %Inhibition of IgG binding to FVIII, %
FVII:C (U/dL)FVII:Ag (U/dL)Anti-FVII:C (BU/mL)80-kd LCh72-kd LChHChC2A280-kd LCh72-kd LChHChC2A2
4.1 101 4.9 > 95 > 95 < 5 < 5 < 5 > 95 > 95 < 5 < 5 < 5 
4.3 98 3.5 > 95 > 95 < 5 < 5 < 5 > 95 > 95 < 5 < 5 < 5 
3.6 87 5.3 > 95 > 95 < 5 < 5 < 5 > 95 > 95 < 5 < 5 < 5 

FVIII indicates factor VIII; FVIII:C, FVIII activity; FVIII:Ag, FVIII antigen; BU, Bethesda unit; LCh, light chain; HCh, heavy chain.

Close Modal

or Create an Account

Close Modal
Close Modal